Year: 2019

First Capital, Inc. Announces Quarterly Dividend

Written by Customer Service on November 19, 2019. Posted in Public Companies.

CORYDON, Ind., Nov. 19, 2019 (GLOBE NEWSWIRE) — The Board of Directors of First Capital, Inc. (NASDAQ: FCAP) has declared a quarterly cash dividend of $0.24 (twenty-four cents) per share of common stock, according to William W. Harrod, President and Chief Executive Officer. The dividend will be paid on December 30, 2019 to shareholders of record as of December 16, 2019. First Capital, Inc. is the holding company for First Harrison Bank. First Harrison currently has eighteen offices in the Indiana communities of Corydon, Edwardsville, Greenville, Floyds Knobs, Palmyra, New Albany, New Salisbury, Jeffersonville, Salem, Lanesville and Charlestown and the Kentucky communities of Shepherdsville, Mt. Washington and Lebanon Junction. Access to First Harrison Bank accounts, including online banking and electronic bill payments, is available...

Interpublic Declares Common Stock Dividend

Written by Customer Service on November 19, 2019. Posted in Dividend Reports And Estimates.

New York, Nov. 19, 2019 (GLOBE NEWSWIRE) — Interpublic Group (NYSE: IPG) today announced that the company’s Board of Directors has declared a quarterly dividend on IPG common stock of $0.235 per share, payable on December 16, 2019, to holders of record at the close of business on December 2, 2019.# # #About InterpublicInterpublic is values-based, data-fueled, and creatively-driven. Major global brands include Acxiom, Craft, FCB (Foote, Cone & Belding), FutureBrand, Golin, Huge, Initiative, Jack Morton, MAGNA, McCann, Momentum, MRM//McCann, MullenLowe Group, Octagon, R/GA, UM and Weber Shandwick. Other leading brands include Avrett Free Ginsberg, Campbell Ewald, Carmichael Lynch, Deutsch, Hill Holliday, ID Media and The Martin Agency. For more information, please visit www.interpublic.com.# # #Contact InformationTom Cunningham(Press)(212)...

Vishay Intertechnology Declares Quarterly Dividend

Written by Customer Service on November 19, 2019. Posted in Dividend Reports And Estimates.

MALVERN, Pa., Nov. 19, 2019 (GLOBE NEWSWIRE) — Vishay Intertechnology, Inc. (NYSE:VSH), one of the world’s largest manufacturers of discrete semiconductors and passive components, announced today that the Company’s Board of Directors declared a dividend of $0.095 per share of common stock and Class B common stock to be paid December 23, 2019 to stockholders of record as of the close of business on December 12, 2019. Future dividends will be subject to Board approval.About VishayVishay Intertechnology, Inc., a Fortune 1000 Company listed on the NYSE (VSH), is one of the world’s largest manufacturers of discrete semiconductors (diodes, MOSFETs, and infrared optoelectronics) and passive electronic components (resistors, inductors, and capacitors). These components are used in virtually all types of electronic devices and...

ANB Canada and Teal Valley Health Announce Termination of Letter of Intent

Written by Customer Service on November 19, 2019. Posted in Mergers And Acquisitions.

TORONTO, Nov. 19, 2019 (GLOBE NEWSWIRE) — ANB Canada Inc. (“ANB”) and Teal Valley Health Inc. (“Teal Valley”) announce the mutual termination of the previously announced letter of intent to merge the respective companies. Additional information on the letter of intent and transactions contemplated thereunder are set out in the joint press release of the companies dated September 27, 2019.About ANB Canada Inc.ANB Canada Inc. is a public company located in Ontario, Canada. ANB provides turnkey Rx, over the counter (“OTC”) and Health and Beauty (“HABA”) sales and distribution to companies that navigate regulatory guidelines and the Food, Drug, Mass, Club, Natural and Specialty, Convenience, eCommerce retailers and the public sector in Canada.About Teal ValleyTeal Valley Health Inc. is a diversified cannabis company headquartered in...

Scorpio Tankers Inc. Announces Purchase of Call Options by President of the Company

Written by Customer Service on November 19, 2019. Posted in Public Companies.

MONACO, Nov. 19, 2019 (GLOBE NEWSWIRE) — Scorpio Tankers Inc. (NYSE:STNG) (“Scorpio Tankers,” or the “Company”) announced that the President of the Company, Robert Bugbee, has purchased call options on 200,000 common shares (or 2,000 call option contracts) of the Company with strike price of $32.00 and an expiration of January 2020 for the consideration of $450,000.About Scorpio Tankers Inc.Scorpio Tankers is a provider of marine transportation of petroleum products worldwide. The Company currently owns or finance leases 124 product tankers (42 LR2 tankers, 12 LR1 tankers, 56 MR tankers and 14 Handymax tankers) with an average age of 3.9 years and bareboat charters-in 10 product tankers (three MR tankers and seven Handymax tankers). In addition, the Company will bareboat charter-in four MR tankers that are currently under construction...

PURE GLOBAL REITERATES MANUFACTURING APPROVALS AND ANNOUNCES FINANCING

Written by Customer Service on November 19, 2019. Posted in Public Companies.

TORONTO, Nov. 19, 2019 (GLOBE NEWSWIRE) — Pure Global Cannabis Inc. (TSX.V:PURE; OTC: PRCNF) (the “Company” or “Pure Global” or “Pure”), an integrated growth-oriented cannabis bulk extracts and consumer products manufacturing company, operating through its wholly-owned subsidiary PureSinse Inc., a Health Canada Licensed Producer under the Cannabis Act, is very pleased to announce that it has received approvals from Health Canada to amend its existing license to add manufacturing capabilities via phase 2 of its already licensed facility in Brampton. Having completed their facility in the spring, the Company can begin cultivation and extraction immediately now that all approvals have been granted. This is a transformational event for the Company as it enables its own production as opposed to previously being dependent on wholesale purchases...

Pfenex to Present at the Evercore ISI HealthCONx Conference 2019

Written by Customer Service on November 19, 2019. Posted in Public Companies.

SAN DIEGO, Nov. 19, 2019 (GLOBE NEWSWIRE) — Pfenex Inc. (NYSE American: PFNX) is a development and licensing biotechnology company focused on leveraging its Pfēnex Expression Technology® to develop and improve protein therapies for unmet patient needs. Using the patented Pfēnex Expression Technology platform, the Company has developed the FDA-approved PF708 product indicated for the treatment of osteoporosis in certain patients at high risk of fracture and created an advanced pipeline of therapeutic equivalents, biologics and vaccines. The Company announced today that Eef Schimmelpennink, President and Chief Executive Officer, will be presenting at the Evercore ISI HealthCONx Conference 2019 on Tuesday, December 3rd, taking place at the Four Seasons Hotel in Boston, Massachusetts.Interested parties can access the live audio webcast...

Akcea and Ionis Announce Closing of Licensing Agreement with Pfizer Inc. for Investigative Antisense Therapy AKCEA-ANGPTL3-L(Rx)

Written by Customer Service on November 19, 2019. Posted in Public Companies.

BOSTON and CARSLBAD, Calif., Nov. 19, 2019 (GLOBE NEWSWIRE) — Akcea Therapeutics, Inc. (NASDAQ: AKCA), a majority-owned affiliate of Ionis Pharmaceuticals, Inc., and Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), today announced the closing of the exclusive licensing agreement with Pfizer Inc. (NYSE:PFE) for AKCEA-ANGPTL3-LRx following expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act). AKCEA-ANGPTL3-LRx is an investigational antisense therapy discovered by Ionis and being developed to treat patients with certain cardiovascular and metabolic diseases. As previously announced, under terms of the agreement Akcea and Ionis will receive a $250 million upfront license fee, which will be split equally between the two companies. Akcea will settle its $125 million obligation to Ionis...

NextCure Announces Closing of Public Offering

Written by Customer Service on November 19, 2019. Posted in Public Companies.

BELTSVILLE, Md., Nov. 19, 2019 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced the closing of its public offering of 4,077,192 shares of its common stock at a public offering price of $36.75 per share. The gross proceeds from the offering, before deducting underwriting discounts and commissions and estimated offering expenses, were approximately $150 million. NextCure’s common stock is listed on The Nasdaq Global Select Market under the ticker symbol “NXTC.”Morgan Stanley, BofA Securities and Piper Jaffray & Co. acted as joint book-running managers for the offering. Needham & Company and BTIG acted as co-managers for the offering.A...

Verisk Elects Laura K. Ipsen to Board of Directors

Written by Customer Service on November 19, 2019. Posted in Public Companies.

JERSEY CITY, N.J., Nov. 19, 2019 (GLOBE NEWSWIRE) — Verisk (Nasdaq:VRSK), a leading data analytics provider, announces the addition of Laura K. Ipsen to its board of directors, effective January 1. Ipsen has more than 25 years of experience as a technology executive. She’s currently president and chief executive officer of Ellucian, which provides software and services that power more than 2,500 higher education institutions in more than 50 countries.“Verisk serves a spectrum of industries in data- and technology-rich environments, and Laura’s decades of experience in these arenas will further strengthen the composition of our board,” said Verisk Chairman, President, and CEO Scott G. Stephenson. “Her knowledge of the cloud, AI, and global energy efforts will challenge our assumptions and push us to continue finding new ways to solve...

Year: 2019

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals